Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
42.28
+0.29 (0.69%)
May 3, 2024, 9:34 AM EDT - Market open

Inari Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018
Market Capitalization
2,4633,7393,4104,5824,252--
Market Cap Growth
-9.64%-25.58%7.77%---
Enterprise Value
2,3933,6553,1164,4354,087-5-12
PE Ratio
-117.74-2285.31-116.52465.67308.36--
PS Ratio
4.737.578.8916.5430.44--
PB Ratio
5.518.048.1819.1621.23--
P/FCF Ratio
133.12125.77-142.55386.98-1198.41--
P/OCF Ratio
96.03104.07-244.07179.792223.83--
EV/Sales Ratio
4.607.408.1316.0129.26-0.09-1.76
EV/EBITDA Ratio
1217.81240.81-166.00290.12250.62-13.291.34
EV/EBIT Ratio
-260.31822.77-120.35403.94273.8816.711.30
EV/FCF Ratio
129.32122.95-130.25374.57-1152.020.561.03
Debt / Equity Ratio
0.070.070.080.12--0.50-0.25
Debt / EBITDA Ratio
16.032.11-1.721.91-56.96-1.10
Debt / FCF Ratio
1.701.08-1.352.47--2.41-0.84
Quick Ratio
2.102.446.855.1413.923.9811.33
Current Ratio
2.713.097.535.7714.864.4412.20
Asset Turnover
0.860.880.781.010.791.43-
Interest Coverage
-44.5022.66-88.0637.2213.15-0.30-10.45
Return on Equity (ROE)
-5.20%-0.40%-7.00%4.30%10.20%3.00%-
Return on Assets (ROA)
-3.90%-0.30%-6.00%3.60%7.80%-3.30%-
Return on Capital (ROIC)
-4.09%1.09%-6.25%3.72%9.20%-4.07%30.87%
Earnings Yield
-0.96%-0.04%-0.86%0.21%0.32%--
FCF Yield
0.75%0.80%-0.70%0.26%-0.08%--
Buyback Yield / Dilution
-5.81%-7.44%4.96%-7.83%-775.66%-16.43%-
Total Shareholder Return
-5.81%-7.44%4.96%-7.83%-775.66%-16.43%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).